CHRISTINE O'CONNOR: Open Payments
NPI 1164765921 · NORWALK, CT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,875 in 60 payments from 24 companies in 2025. Trend: 2023 $658 · 2024 $1,251 · 2025 $2,875
Food & beverage: $1,315Travel & lodging: $830Consulting: $731
| Company | Payments | Amount |
|---|---|---|
| Genmab U.S., Inc. | 5 | $1,686 |
| ABBVIE INC. | 4 | $191 |
| Celgene Corporation | 15 | $165 |
| Janssen Biotech, Inc. | 4 | $127 |
| Novartis Pharmaceuticals Corporation | 4 | $105 |
| AstraZeneca Pharmaceuticals LP | 4 | $102 |
| PFIZER INC. | 3 | $63 |
| Eisai Inc. | 2 | $47 |
| E.R. Squibb & Sons, L.L.C. | 2 | $41 |
| Legend Biotech USA Inc. | 2 | $35 |
Products named: Epkinly, REBLOZYL, DARZALEX, OPDIVO, ENHERTU, Fabhalta, Lenvima, IMBRUVICA.
Industry payments across CT — which companies pay providers there.
